According to bioAffinity Technologies's latest financial reports the company has $2.82 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $11.41 M | 738.85% |
2021-12-31 | $1.36 M | 1537.19% |
2020-12-31 | $0.08 M |